Rchr
J-GLOBAL ID:201601003830801963
Update date: Apr. 15, 2024
TETSUFUMI KANAZAWA
カナザワ テツフミ | TETSUFUMI KANAZAWA
Affiliation and department:
Job title:
Full Professor
Research keywords (12):
大規模データ
, クロザピン
, ナショナルデータベース
, 分子遺伝学
, 臨床遺伝学
, 統合失調症
, Atypische Psychosis
, 躁うつ病
, Periodic Psychosis
, Schizophrenia
, 非定型精神病
, Bipolar Disorder
Research theme for competitive and other funds (12):
- 2022 - 2026 Effectiveness of EMDR in patients with adult PTSD: a randomized controlled trial in Japan.
- 2022 - 2025 Development of biomarkers for gender dysphoria based on the fluctuation of establishment of sex-specific epigenetic signature.
- 2022 - 2025 Research on the pathophysiology of acute transient psychosis using animal model
- 2019 - 2022 CD10+CD19ー細胞によるM2b単球誘導機序の解明
- 2017 - 2020 Whole genome sequencing analysis for investigation of biomarker candidates for Gender Dysphoria
- 2016 - 2020 What exists between schizophrenia and bipolar disorder ~genomic analysis by whole-genome resequence~
- 2015 - 2017 Development of biomarker related to gender dysphoria (gender identity disorder) based on whole exome sequencing analysis.
- 2014 - 2017 Mechanisms of action in EMDR
- 2010 - 2013 The epidemiological survey of the intermittent psychosis between schizophrenia and affective disorder
- 2011 - 2012 Genome-Wide association study of atypical psychisis
- 内因性精神病における分子遺伝学の関与
- Genetic approach to major psychiatric disorder
Show all
Papers (120):
-
Taishiro Kishimoto, Shotaro Kinoshita, Momoko Kitazawa, Akitoyo Hishimoto, Takeshi Asami, Akira Suda, Shogyoku Bun, Toshiaki Kikuchi, Mitsuhiro Sado, Akihiro Takamiya, et al. Live two-way video versus face-to-face treatment for depression, anxiety, and obsessive-compulsive disorder: A 24-week randomized controlled trial. Psychiatry and Clinical Neurosciences. 2023
-
Toshinori Chiba, Kentarou Ide, Misa Murakami, Nao Kobayashi, Taiki Oka, Fumiya Nakai, Rumi Yorizawa, Yuka Miyake, Toshitaka Hamamura, Masaru Honjo, et al. Event-related PTSD symptoms as a high-risk factor for suicide: longitudinal observational study. Nature Mental Health. 2023. 1. 12. 1013-1022
-
Shotaro Kinoshita, Momoko Kitazawa, Yoshinari Abe, Akira Suda, Takashi Nakamae, Tetsufumi Kanazawa, Hiroaki Tomita, Akitoyo Hishimoto, Taishiro Kishimoto. Psychiatrists’ Perspectives on Advantages, Disadvantages and Challenging for Promotion Related to Telemedicine: Japan’s Clinical Experience During COVID-19 Pandemic. Journal of Technology in Behavioral Science. 2023
-
Tomihisa Niitsu, Norio Yasui-Furukori, Ken Inada, Tetsufumi Kanazawa, Masaomi Iyo, Takefumi Ueno, Ryota Hashimoto. Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey. Schizophrenia research. 2023
-
川端 康雄, 吉田 誠司, 若林 暁子, 杉本 峻也, 上島 奈菜子, 新田 雅彦, 金 泰子, 金沢 徹文. トラウマ受傷した聴覚障害児に対しEMDRが奏効した1例. 子どもの心とからだ. 2023. 32. 2. 324-324
more...
MISC (115):
-
今津 伸一, 釜瀬 貴之, 久保 洋一郎, 木下 真也, 金沢 徹文. 【治療抵抗性うつ病への挑戦】治療抵抗性うつ病に対するニューロモデュレーション 修正型電気けいれん療法と反復経頭蓋磁気刺激療法の比較を含めて. 精神科治療学. 2022. 37. 8. 871-876
-
山本 健介, 藤本 健士郎, 辻 明里, 久保 洋一郎, 木下 真也, 金沢 徹文. 面談を契機に氷解した特殊な死生観を有する解離性障害の1例 解離性障害ならびに自閉スペクトラム症への多職種連携による心理的介入の重要性について. 精神神経学雑誌. 2022. 124. 8. 533-537
-
藤本 健士郎, 岡山 達志, 金沢 徹文. 【精神科診療におけるたとえ話の効用】精神科における診療をさらに一段押し上げるたとえ話. 精神科治療学. 2022. 37. 7. 757-760
-
川端 康雄, 上島 奈菜子, 吉田 誠司, 新田 雅彦, 金 泰子, 金沢 徹文. トラウマ受傷した聴覚障害児に対しEMDRが奏効した1例. 子どもの心とからだ. 2022. 31. 1. 105-105
-
藤澤 玲子, 稲葉 惟子, 渡邉 大督, 酒井 聡至, 重本 翔, 木下 真也, 佐野 寛行, 金綱 規夫, 寺前 純吾, 金沢 徹文, et al. 確診に難渋した外因性甲状腺中毒症の一例. 日本内分泌学会雑誌. 2022. 98. 1. 354-354
more...
Lectures and oral presentations (2):
-
The validation of schizophrenia diagnosed by DSM
(World Congress of Psychiatric Genetics 2008)
-
SELENBP1 gene expression and family based study
(World Congress of Psychiatric Genetics 2007)
Education (1):
- 1994 - 2000 Osaka Medical College Faculty of Medicine
Professional career (1):
- Ph.D (Osaka Medical College)
Work history (1):
- 2020/04 - 現在 Osaka Medical and Pharmaceuticall University, Faculty of Medicine Department of Neuropsychiatry Full Professor
Awards (1):
- 2006 - Best Poster Award (WCPG, 2006)
Association Membership(s) (1):
The Japanese Society of Psychiatry and Neurology
Return to Previous Page